AML is swarming with challenges

Role of MAP‐K pathway and oncogenic BRAF mutations in metastatic melanoma

Nicholas Cross, MA, PhD, FRCPath Professor of Human Genetics Director, Wessex Regional Genetics Laboratory Salisbury District Hospital, Salisbury, UK

Introduction to the Cause of CML

JAK Mechanism of Action

Broad pipeline targeting anticancer immune pathways

Featured Videos